Gisela Schwab

Board member

Independent board member since 2011

Nationality: German

Age: 55

Dr Schwab is Executive Vice President Development and Chief Medical Officer at Exelixis, Inc, South San Francisco, US.

Prior to joining Exelixis, Inc in the year 2006, Dr Schwab served as Senior Vice President and Chief Medical Officer at Abgenix, Inc., Fremont, US, and was employed in several positions at Amgen, Inc, US, following their acquisition of Abgenix.

Dr Schwab is Doctor of Medicine from the University of Heidelberg with board certification in internal medicine and hematology/oncology.

Dr Schwab has great experience within the pharmaceutical industry in managing early and late-stage development activities (target selection, pre-clinical, pharmacokinetic, clinical, and regulatory development) of biotechnological compounds and small molecules, filing of INDs and BLAs/MAAs, building and managing development teams, and leading to worldwide product registration (17+ years' experience).

Furthermore she holds great experience in filing of INDs and BLAs/MAAs and in building and managing development teams ranging from several to 150+ people.

Dr Schwab is presenter and author of numerous pre-clinical and clinical study results and book chapters.